All

× UPDATE! Updated as of 05 April 2024.
Records 101 to 120 of 32212
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1216 RECOMBINANT HUMAN ERYTHROPOIETIN DYPOTIN 4000 IU/ mL (PRE-FILLED SYRINGE) Solution for Injection Prescription Drug (Rx) HEMATOPOIETIC GROWTH FACTOR NCPC Genetech Biotechnology Co., Ltd China Automatic Renewal 29 March 2022 09 May 2027
View BR-1217 Streptokinase None 1,500,000 IU Powder For Injection (IV) Prescription Drug (RX) - Dae Han New Pharm. Co., LTD. Korea Renewal 27 October 2022 21 May 2026
View BR-1218 Isophane Insulin Human Insulatard 100 IU/mL Solution for Injection (SC) Prescription Drug (Rx) Intermediate Acting Insulin Novo Nordisk Production SAS France Automatic Renewal 26 March 2022 02 June 2027
View BR-1219 Insulin Human (Regular) Actrapid 100 IU/mL Solution for Injection (SC) Prescription Drug (Rx) Short Acting Insulin Novo Nordisk Production SAS France Automatic Renewal 31 March 2022 02 June 2027
View BR-1220 Biphasic Insulin Mixtard 30 100 IU/mL Suspension for Injection (SC) Prescription Drug (Rx) Intermediate Acting Insulin Novo Nordisk Production SAS France Renewal 31 March 2022 02 June 2027
View BR-1221_PI_01.pdf BR-1221 Adalimumab Humira 40 mg /0.4 mL Solution for Injection (SC) Prescription Drug (RX) - Vetter Pharma-Fertigung GmbH & Co. KG Germany Initial (from Monitored Release) 05 August 2022 17 July 2027
View BR-1222 Pegfilgrastim Neulastim 6 mg/0.6 mL Solution For Injection (SC) Prescription Drug (RX) - Amgen Manufacturing Limited U.S.A - 18 March 2022 14 July 2027
View BR-1223 Filgrastim Neupogen 300 mcg/mL Solution For Injection (SC/IV) Prescription Drug (RX) - Amgen Manufacturing Limited U.S.A - 18 March 2022 14 July 2027
View BR-1224 Filgrastim Biofil 300 mcg/mL Solution For Injection (IV/SC) Prescription Drug (RX) - Sinergium Biotech S.A. Argentine Republic Renewal 26 August 2022 08 August 2027
View BR-1225_PI_01.pdf BR-1225 Insulin Degludec + Liraglutide Xultophy 100 U/3.6 mg/mL Solution for Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark Initial (from Monitored Release) 24 October 2022 10 August 2027
View BR-1226 Insulin Detemir Levemir Penfill 100 U/ml Solution for injection Prescription Drug (RX) Insulin and analogue for injection, long-acting Novo Nordisk A/S Denmark Renewal 09 June 2022 05 September 2027
View BR-1232 Botulinum Toxin Type A (from Clostridium botulinum) Xeomin 50 Units Powder For Solution For Injection (IM) Prescription Drug (RX) Muscle Relaxant IDT Biologika GmbH Germany Automatic Renewal 30 August 2022 19 September 2027
View BR-1233 Botulinum Toxin Type A (from Clostridium botulinum) Xeomin 100 units Powder For Solution For Injection (IM) Prescription Drug (RX) Muscle Relaxant Merz Pharma GmbH & co. KGaA Germany Automatic Renewal 30 August 2022 19 September 2027
View BR-1234 Botulinum Toxin* Type A (*from Clostridium botulinum) Xeomin 50 Units Powder for Solution for Injection (IM) Prescription Drug (Rx) Muscle Relaxant Merz Pharma GmbH & Co. KGaA Germany Renewal 25 August 2022 19 September 2027
View BR-1235 Isophane Insulin Human, Recombinant DNA Jusline N 100 units/mL Sterile Suspension For Injection ( Sc ) Prescription Drug (RX) Intermediate-acting Insulin Gulf Pharmaceutical Industries ( Julphar ) UAE Renewal 28 March 2023 14 March 2028
View BR-1236 Regular Insulin Human, Recombinant DNA Jusline R 100 units/mL Sterile Suspension For Injection ( Sc ) Prescription Drug (RX) Short-acting Insulin Gulf Pharmaceutical Industries ( Julphar ) UAE Renewal 20 March 2023 14 March 2028
View BR-1237 Neutral Insulin Human + Isophane Insulin Human, Recombinant DNA Jusline 30/70 100 units/mL ( 30% as neutral insulin human/ 70% as isophane insulin human ) Sterile Suspension For Injection ( Sc ) Prescription Drug (RX) Intermediate-acting Insulin Gulf Pharmaceutical Industries ( Julphar ) UAE Renewal 22 March 2023 14 March 2028
View BR-1240 Trastuzumab Hertraz 150 mg Powder for Concentrate for Solution for Infusion (IV) Prescription Drug (RX) Monoclonal Antibodies Biocon Biologics India Limited India Initial (from Monitored Release) 29 March 2023 05 October 2027
View BR-1241 Trastuzumab Hertraz 440 mg Powder For Concentrate For Solution For Infusion Prescription Drug (RX) Monoclonal Antibodies Biocon Limited India Initial (from Monitored Release) 18 August 2022 05 October 2027
View BR-1243 Human Normal Immunoglobulin Privigen 100 mg/mL (10% w/v) Solution for Infusion (IV) Prescription Drug (RX) - CSL Behring AG Switzerland Renewal 28 June 2022 05 October 2027